BUFFALO, N.Y. (WIVB) — A Buffalo pharmacy agreed to pay the United States $141,727 to resolve allegations that it violated the recordkeeping provisions of the Controlled Substances Act (CSA) and overcharged federal health care programs, the United States Attorney’s Office said.
Officials said an inspection by the DEA showed that between Jan. 1, 2018, and Feb. 1, 2021, Dexter Pharmacy allegedly failed to maintain accurate records relating to its purchases and sales for certain controlled substances.
According to officials, the CSA requires entities that sell controlled substances to keep certain records and conduct periodic inventories to “prevent against the diversion” of controlled substances.
The pharmacy also allegedly billed federal healthcare programs for medications, which included controlled substances, that it never sold, the attorney’s office said.
Latest Local News
Katie Skoog joined the News 4 team in April 2024. She is a graduate from the University at Buffalo. You can view more of her work here.
Copyright 2024 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
For the latest news, weather, sports, and streaming video, head to News 4 Buffalo.
Source Agencies
